Gene · 7531
Papers2,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation. | Nat Commun | 2022 | 36376293 | PubTator, text mining | PubMed |
| Genome-Wide Transcriptional Profiling Reveals PHACTR1 as a Novel Molecular Target of Resveratrol in Endothelial Homeostasis. | Nutrients | 2022 | 36364780 | PubTator, text mining | PubMed |
| Interplay between Autophagy and Herpes Simplex Virus Type 1: ICP34.5, One of the Main Actors. | Int J Mol Sci | 2022 | 36362429 | PubTator, text mining | PubMed |
| Gene Expression Detects the Factors Influencing the Reproductive Success and the Survival Rates of Paracentrotus lividus Offspring. | Int J Mol Sci | 2022 | 36361581 | PubTator, text mining | PubMed |
| Proteomic Landscape and Deduced Functions of the Cardiac 14-3-3 Protein Interactome. | Cells | 2022 | 36359893 | PubTator, text mining | PubMed |
| Mitoferrin, Cellular and Mitochondrial Iron Homeostasis. | Cells | 2022 | 36359860 | PubTator, text mining | PubMed |
| Comparative Transcriptomics and Proteomics of Cancer Cell Lines Cultivated by Physiological and Commercial Media. | Biomolecules | 2022 | 36358924 | PubTator, text mining | PubMed |
| Inhibition of 14-3-3ε by K50 acetylation activates YAP1 to promote cholangiocarcinoma growth. | Exp Cell Res | 2022 | 36341908 | PubTator, text mining | PubMed |
| Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples. | Explor Target Antitumor Ther | 2022 | 36338518 | PubTator, text mining | PubMed |
| Structural and functional basis of mammalian microRNA biogenesis by Dicer. | Mol Cell | 2022 | 36332606 | PubTator, text mining | PubMed |
| Towards a potential pan-cancer prognostic signature for gene expression based on probesets and ensemble machine learning. | BioData Min | 2022 | 36329531 | PubTator, text mining | PubMed |
| Clinical evaluation of rare copy number variations identified by chromosomal microarray in a Hungarian neurodevelopmental disorder patient cohort. | Mol Cytogenet | 2022 | 36320065 | PubTator, text mining | PubMed |
| Dengue virus downregulates TNFR1- and TLR3-stimulated NF-κB activation by targeting RIPK1. | Front Cell Infect Microbiol | 2022 | 36310878 | PubTator, text mining | PubMed |
| A distinct mammalian disome collision interface harbors K63-linked polyubiquitination of uS10 to trigger hRQT-mediated subunit dissociation. | Nat Commun | 2022 | 36302773 | PubTator, text mining | PubMed |
| Foot-and-Mouth Disease Virus: Molecular Interplays with IFN Response and the Importance of the Model. | Viruses | 2022 | 36298684 | PubTator, text mining | PubMed |
| Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery. | Pharmaceuticals (Basel) | 2022 | 36297381 | PubTator, text mining | PubMed |
| Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature. | Biomedicines | 2022 | 36289829 | PubTator, text mining | PubMed |
| Metanephric stromal tumor with BRAF V600E mutation in an adult patient: Case report and literature review. | Front Oncol | 2022 | 36276087 | PubTator, text mining | PubMed |
| UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination. | Oncogene | 2022 | 36273042 | PubTator, text mining | PubMed |
| The RIG-I receptor adopts two different conformations for distinguishing host from viral RNA ligands. | Mol Cell | 2022 | 36272408 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7531/papers?page=19